Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10583392rdf:typepubmed:Citationlld:pubmed
pubmed-article:10583392lifeskim:mentionsumls-concept:C0008109lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0026820lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0003765lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0024337lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0079284lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C1441672lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0311404lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0524724lld:lifeskim
pubmed-article:10583392lifeskim:mentionsumls-concept:C0185026lld:lifeskim
pubmed-article:10583392pubmed:issue3lld:pubmed
pubmed-article:10583392pubmed:dateCreated2000-1-31lld:pubmed
pubmed-article:10583392pubmed:abstractTextThe chimeric peptide [Lys(-2)-Arg(-1)]-sarafotoxin-S6b (KR-SRTb) designed from the Lys-2-Arg-1 dipeptide of the endothelin pro-sequence and the sarafotoxin-S6b sequence was synthesized. Its contractile activity was found to be decreased markedly when compared with that of the parent SRTb. In contrast, the extension by the Lys-Arg dipeptide was found to increase the formation of the native disulfide isomer (82/18 versus 96/4) when the reaction was carried out in the presence of redox reagents. The solution structure of KR-SRTb was determined by NMR as a function of pH. In the carboxylic acid state, the structure consists of the cystine-stabilized alpha-helical motif, with the alpha-helical part spanning residues 9-15, and of an unstructured C-terminal tail. In the carboxylate state, the structure is characterized by a salt-bridge between Arg(-1) and Asp8, which we identified previously in the [Lys(-2)-Arg(-1)]-endothelin-1 peptide (KR-ET-1). The fact that this salt-bridge is commonly observed in KR-SRTb and KR-ET-1, despite the 33% sequence difference between the corresponding parental peptides, highlights the remarkable adaptability of the Lys-Arg extension for the formation of a special salt-bridge. As a consequence, this salt-bridge, which does not depend on either the 4-7 sequence of the loop or the C-terminal sequence, appears to be particularly well suited to improve the stability of the cystine-stabilized alpha-helical motif. Therefore, because of its high yield in the native disulfide arrangement and its high permissiveness for sequence mutation in the 4-7 loop, such a stabilized cystine-stabilized alpha-helical motif could be a valuable scaffold for the presentation of a library of constrained short peptides.lld:pubmed
pubmed-article:10583392pubmed:languageenglld:pubmed
pubmed-article:10583392pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:citationSubsetIMlld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583392pubmed:statusMEDLINElld:pubmed
pubmed-article:10583392pubmed:monthDeclld:pubmed
pubmed-article:10583392pubmed:issn0014-2956lld:pubmed
pubmed-article:10583392pubmed:authorpubmed-author:KobayashiYYlld:pubmed
pubmed-article:10583392pubmed:authorpubmed-author:KuboSSlld:pubmed
pubmed-article:10583392pubmed:authorpubmed-author:ChinoNNlld:pubmed
pubmed-article:10583392pubmed:authorpubmed-author:WatanabeT XTXlld:pubmed
pubmed-article:10583392pubmed:authorpubmed-author:ChicheLLlld:pubmed
pubmed-article:10583392pubmed:authorpubmed-author:AumelasAAlld:pubmed
pubmed-article:10583392pubmed:issnTypePrintlld:pubmed
pubmed-article:10583392pubmed:volume266lld:pubmed
pubmed-article:10583392pubmed:ownerNLMlld:pubmed
pubmed-article:10583392pubmed:authorsCompleteYlld:pubmed
pubmed-article:10583392pubmed:pagination977-85lld:pubmed
pubmed-article:10583392pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:meshHeadingpubmed-meshheading:10583392...lld:pubmed
pubmed-article:10583392pubmed:year1999lld:pubmed
pubmed-article:10583392pubmed:articleTitleThe chimeric peptide [Lys(-2)-Arg(-1)]-sarafotoxin-S6b, composed of the endothelin pro-sequence and sarafotoxin, retains the salt-bridge staple between Arg(-1) and Asp8 previously observed in [Lys(-2)-Arg(-1)]-endothelin. Implications of this salt-bridge in the contractile activity and the oxidative folding reaction.lld:pubmed
pubmed-article:10583392pubmed:affiliationCentre de Biochimie Structurale, CNRS UMR C9955, INSERM U414, Faculté de Pharmacie, Montpellier, France. aumelas@cbs.univ-montp1.frlld:pubmed
pubmed-article:10583392pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10583392pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10583392pubmed:publicationTypeIn Vitrolld:pubmed